4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol

C140H181N35O8 — CID 160828830

IUPAC4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol
SMILESCN(C)c1ccnc2cc(O)c(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)cc12.CN(c1ccc(-c2cc3c(=O)[nH]cnc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2cc3ccnc(C#N)c3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2cc3cncnc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN1C(=O)CCc2cc(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)c(O)cc21.Cc1ncc2cc(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)c(O)cc2n1
InChIInChI=1S/C25H34N6O.C24H28N6O.C24H33N5O2.C23H30N6O.C22H28N6O2.C22H28N6O/c1-24(2)14-16(15-25(3,4)29-24)31(7)23-9-8-19(27-28-23)18-12-17-20(13-22(18)32)26-11-10-21(17)30(5)6;1-23(2)12-16(13-24(3,4)29-23)30(5)22-7-6-19(27-28-22)18-10-15-8-9-26-20(14-25)17(15)11-21(18)31;1-23(2)13-16(14-24(3,4)27-23)28(5)21-9-8-18(25-26-21)17-11-15-7-10-22(31)29(6)19(15)12-20(17)30;1-14-24-13-15-9-17(20(30)10-19(15)25-14)18-7-8-21(27-26-18)29(6)16-11-22(2,3)28-23(4,5)12-16;1-21(2)10-13(11-22(3,4)27-21)28(5)19-7-6-16(25-26-19)14-8-15-17(9-18(14)29)23-12-24-20(15)30;1-21(2)10-15(11-22(3,4)27-21)28(5)20-7-6-17(25-26-20)16-8-14-12-23-13-24-18(14)9-19(16)29/h8-13,16,29,32H,14-15H2,1-7H3;6-11,16,29,31H,12-13H2,1-5H3;8-9,11-12,16,27,30H,7,10,13-14H2,1-6H3;7-10,13,16,28,30H,11-12H2,1-6H3;6-9,12-13,27,29H,10-11H2,1-5H3,(H,23,24,30);6-9,12-13,15,27,29H,10-11H2,1-5H3
InChIKeySGNMGVFYJCQMMF-UHFFFAOYSA-N
MW2482.22 g/mol
LogP21.94
Rot. Bonds19

About 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol

4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol (PubChem CID 160828830) has the molecular formula C140H181N35O8 and a molecular weight of 2482.22 g/mol. Its IUPAC name is 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol.

Molecular Properties

Compound Name4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol
PubChem CID160828830
Molecular FormulaC140H181N35O8
Molecular Weight2482.22 g/mol
Exact Mass2480.48
IUPAC Name4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol
SMILESCN(C)c1ccnc2cc(O)c(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)cc12.CN(c1ccc(-c2cc3c(=O)[nH]cnc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2cc3ccnc(C#N)c3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2cc3cncnc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN1C(=O)CCc2cc(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)c(O)cc21.Cc1ncc2cc(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)c(O)cc2n1
InChIInChI=1S/C25H34N6O.C24H28N6O.C24H33N5O2.C23H30N6O.C22H28N6O2.C22H28N6O/c1-24(2)14-16(15-25(3,4)29-24)31(7)23-9-8-19(27-28-23)18-12-17-20(13-22(18)32)26-11-10-21(17)30(5)6;1-23(2)12-16(13-24(3,4)29-23)30(5)22-7-6-19(27-28-22)18-10-15-8-9-26-20(14-25)17(15)11-21(18)31;1-23(2)13-16(14-24(3,4)27-23)28(5)21-9-8-18(25-26-21)17-11-15-7-10-22(31)29(6)19(15)12-20(17)30;1-14-24-13-15-9-17(20(30)10-19(15)25-14)18-7-8-21(27-26-18)29(6)16-11-22(2,3)28-23(4,5)12-16;1-21(2)10-13(11-22(3,4)27-21)28(5)19-7-6-16(25-26-19)14-8-15-17(9-18(14)29)23-12-24-20(15)30;1-21(2)10-15(11-22(3,4)27-21)28(5)20-7-6-17(25-26-20)16-8-14-12-23-13-24-18(14)9-19(16)29/h8-13,16,29,32H,14-15H2,1-7H3;6-11,16,29,31H,12-13H2,1-5H3;8-9,11-12,16,27,30H,7,10,13-14H2,1-6H3;7-10,13,16,28,30H,11-12H2,1-6H3;6-9,12-13,27,29H,10-11H2,1-5H3,(H,23,24,30);6-9,12-13,15,27,29H,10-11H2,1-5H3
InChIKeySGNMGVFYJCQMMF-UHFFFAOYSA-N
XLogP21.94
TPSA538.11 Ų
H-Bond Donors13
H-Bond Acceptors41
Rotatable Bonds19
Heavy Atoms183
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002482.22
LogP ≤ 521.94
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1041

Analyze 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol?
The IUPAC name of 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol (CID 160828830) is 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol.
What is the SMILES notation for 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol?
The canonical SMILES for 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol is CN(C)c1ccnc2cc(O)c(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)cc12.CN(c1ccc(-c2cc3c(=O)[nH]cnc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2cc3ccnc(C#N)c3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2cc3cncnc3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN1C(=O)CCc2cc(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)c(O)cc21.Cc1ncc2cc(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)c(O)cc2n1.
What is the InChIKey of 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol?
The InChIKey is SGNMGVFYJCQMMF-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H34N6O.C24H28N6O.C24H33N5O2.C23H30N6O.C22H28N6O2.C22H28N6O/c1-24(2)14-16(15-25(3,4)29-24)31(7)23-9-8-19(27-28-23)18-12-17-20(13-22(18)32)26-11-10-21(17)30(5)6;1-23(2)12-16(13-24(3,4)29-23)30(5)22-7-6-19(27-28-22)18-10-15-8-9-26-20(14-25)17(15)11-21(18)31;1-23(2)13-16(14-24(3,4)27-23)28(5)21-9-8-18(25-26-21)17-11-15-7-10-22(31)29(6)19(15)12-20(17)30;1-14-24-13-15-9-17(20(30)10-19(15)25-14)18-7-8-21(27-26-18)29(6)16-11-22(2,3)28-23(4,5)12-16;1-21(2)10-13(11-22(3,4)27-21)28(5)19-7-6-16(25-26-19)14-8-15-17(9-18(14)29)23-12-24-20(15)30;1-21(2)10-15(11-22(3,4)27-21)28(5)20-7-6-17(25-26-20)16-8-14-12-23-13-24-18(14)9-19(16)29/h8-13,16,29,32H,14-15H2,1-7H3;6-11,16,29,31H,12-13H2,1-5H3;8-9,11-12,16,27,30H,7,10,13-14H2,1-6H3;7-10,13,16,28,30H,11-12H2,1-6H3;6-9,12-13,27,29H,10-11H2,1-5H3,(H,23,24,30);6-9,12-13,15,27,29H,10-11H2,1-5H3.
What are the key properties of 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol?
4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol has a molecular weight of 2482.22 g/mol, XLogP of 21.94, 19 rotatable bonds, 13 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(dimethylamino)-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3,4-dihydroquinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]isoquinoline-1-carbonitrile;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3H-quinazolin-4-one;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinazolin-7-ol is sourced from PubChem (CID 160828830), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).